E. Megan Flynn

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 398 citations · Full text

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 343 citations · Full text

Drug-tolerant Cancer Cells, Medicine, Anti-cancer Agent +7

A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications

E. Megan Flynn, Oscar W. Huang, Florence Poy et al. · Structure · 2015 · 209 citations · Full text

Chromatin, Chromatin Remodeling, Epigenetic Change +6

Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT

Raymond C. Trievel, E. Megan Flynn, Robert L. Houtz et al. · Nature Structural & Molecular Biology · 2003 · 130 citations

Biochemistry, Natural Sciences, Molecular Biology +5

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 117 citations · Full text

Molecular Biology, Chemical Biology, Pharmaceutical Chemistry +17